Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1813-1816, May 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, M.
Right arrow Articles by Onishi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, M.
Right arrow Articles by Onishi, S.

Transactivation of Transforming Growth Factor {alpha} Gene by Hepatitis B Virus preS1

Masafumi Ono, Keiko Morisawa, Jing Nie, Katsuya Ota, Taketoshi Taniguchi, Toshiji Saibara and Saburo Onishi1

The First Department of Internal Medicine [M. O., T. S., S. O.] and Laboratory of Molecular Biology, Medical Research Center [K. M., J. N., K. O., T. T.], Kochi Medical School, Okoh, Nankoku Kochi 783-8505, Japan

Hepatitis B virus (HBV) causes acute and chronic liver injury, and integration of HBV DNA is considered to be an important pathogenic determinant for hepatocarcinogenesis and tumor development. Transforming growth factor {alpha} (TGF-{alpha}) drastically accelerates hepatocarcinogenesis when it is overexpressed in TGF-{alpha} transgenic mice (C. Jhappan et al., Cell, 61: 1137–1146, 1990). In HBV-infected patients, hepatocellular carcinoma (HCC) cells show elevated expression of TGF-{alpha} (C. C. Hsia et al., J. Med. Virol., 43: 216–221, 1994), the mechanism for which, however, has not been clarified yet. We here show that preS1, a part of the HBV large surface protein, carries a transcriptional transactivation domain and activates the transcription of the TGF-{alpha} gene by 2-fold in human HCC HuH6 cells. The responsive elements are restricted to the 315-bp segment of the proximal TGF-{alpha} promoter (-373 to -59). Furthermore, the expression of TGF-{alpha} was markedly increased in permanently preS1-producing HuH6 transformants. The crucial role for HBV preS1 in hepatocarcinogenesis and tumor development through transactivation of the TGF-{alpha} gene may give us new insight into the understanding of pathogenesis and therapy of viral hepatocarcinogenesis.

1 To whom requests for reprints should be addressed, at The First Department of Medicine, Kochi Medical School, Okoh, Nankoku, Kochi 783-8505, Japan. Phone and Fax: 81(888)80-2338; E-Mail: onishis@med.kochi-ms.ac.jp.

Received 12/22/97. Accepted 3/19/98.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
T. T.-T. Huy, H. Ushijima, K. M. Win, P. Luengrojanakul, P. K. Shrestha, Z.-H. Zhong, A. V. Smirnov, T. C. Taltavull, T. Sata, and K. Abe
High Prevalence of Hepatitis B Virus Pre-S Mutant in Countries Where It Is Endemic and Its Relationship with Genotype and Chronicity
J. Clin. Microbiol., December 1, 2003; 41(12): 5449 - 5455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.